Skip to main content

$0.010 (0%)

High

$0.01

Low

$0.01

Trades

2

Turnover

$3,150

Volume

290,000
30 June 2023 at 12:03pm
Register to track NGS and receive email alerts.
Subject
NGS Ann: Quarterly Activities and Cash Flow Report - September 21

NGS Ann: NGS to present at the South-West Connect ASX Showcase

NGS Ann: NGS Quarterly Webinar Details

NGS Ann: Prospectus - Listed Options

NGS Ann: Results of Meeting

NGS Ann: NGS signs Southeast Asia and China distribution agreement

NGS Ann: New Chinese distribution agreement with Ultrahealth Group

NGS Ann: Notice of General Meeting/Proxy Form

NGS Ann: Investor Webinar Presentation

NGS Ann: Cleansing Notice

NGS Ann: Application for quotation of securities - NGS

NGS Ann: Positive Clinical Trial Results for Boys 10 and over

NGS Ann: Proposed issue of securities - NGS

NGS Ann: NGS finalises $5m capital raise for continued growth

NGS Ann: Notification of cessation of securities - NGS

NGS Ann: Trading Halt

NGS Ann: NGS Launches Nutritional Shake Range for Boys 10 and over

NGS Ann: Notification regarding unquoted securities - NGS

NGS Ann: Appendix 4D and Half Year Report

NGS Ann: NGS executes supply agreement with Chemist Warehouse China

NGS Ann: Cleansing Notice

NGS Ann: Application for quotation of securities - NGS

NGS Ann: Quarterly Activities and Cash Flow Report - June 21

NGS Ann: NGS Quarterly Webinar Details

NGS Ann: ADHD Kids Stimulant Trial - Clarification Announcement

NGS Ann: NGS Appoints Senior Leaders to Drive International Growth

NGS Ann: Healthy Height ADHD Kids Stimulant Trial

NGS Ann: AGM Results

NGS Ann: NGS surpasses US$500k of Healthy Height sales in Italy

NGS Ann: AGM Presentation

NGS Ann: AGM Update

NGS Ann: NGS to present at Gold Coast Investment Showcase

NGS Ann: Change of Local Agent and Australian Office

NGS Ann: NGS to Present at Emerging Food & Beverage Conference

NGS Ann: Notice of Annual General Meeting/Proxy Form

NGS Ann: NGS Launches Clinically Proven Nutrition Bar

NGS Ann: Binding MOU signed for NZ production

NGS Ann: Appendix 2A

NGS Ann: Release of Shares From Escrow

NGS Ann: Appendix 3G - Gavin Thomas Options

NGS Ann: NGS Quarterly webinar details

NGS Ann: Quarterly Activities and Cash Flow Report - March 21

NGS Ann: NGS Secures Rights to Trademark in China

NGS Ann: NGS to present at ConsumerOpps Virtual Investment Conference

NGS Ann: Appendix 4G

NGS Ann: 2020 Corporate Governance Statement

NGS Ann: Annual Report to shareholders

NGS Ann: NGS to present at Market Eye Meet the CEO series

NGS Ann: NGS Healthy Height - EU Debut

NGS Ann: Proposed issue of Securities - NGS

Register to track NGS and receive email alerts.